Translational Development Acquisition TDAC
NASDAQ TDAC
$10.85 +0.01 (+0.09%)
At close: Sep 29, 2026 · 4:00 PM EDT

Translational Development Acquisition Corp. (TDAC) EPS (Basic) (2024 - 2026)

Updated

Translational Development Acquisition (TDAC) reported EPS (Basic) of $0.04 for Q2 2026, down 40.6% from $0.07 a year earlier and down 27.6% from the prior quarter.

Analysis

Translational Development Acquisition Corp. (TDAC) EPS (Basic) (2024 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, Translational Development Acquisition's EPS (Basic) came in at $0.26, up 85.7% year-over-year; for FY2025, it was $0.37.

  • By year, EPS (Basic) came in at -$0.01 in FY2024 and $5,994 in FY2023.
  • The Q2 2026 figure ranks as the lowest quarterly EPS (Basic) since Q4 2024.
  • Per Business Quant data, the three quarters before Q2 2026 came in at $0.06 (Q1 2026), $0.09 (Q4 2025) and $0.08 (Q3 2025).
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 0.04
Mar 31, 2026 0.06
Dec 31, 2025 0.09
Sep 30, 2025 0.08
Jun 30, 2025 0.07
Mar 31, 2025 0.07
Dec 31, 2024 0.00
Sep 30, 2024 -0.02
API Access

Translational Development Acquisition Corp. EPS (Basic) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=eps-basic&ticker=TDAC&period=max&api_key=YOUR_API_KEY